| Literature DB >> 23538680 |
María Dolores Sánchez-Tembleque1, Carmen Corella, Jose L Pérez-Calle.
Abstract
The patient with inflammatory bowel disease will be predisposed to numerous infections due their immune status. It is therefore important to understand the immune and serologic status at diagnosis and to put the patient into an adapted vaccination program. This program would be applied differently according to two patient groups: the immunocompromised and the non-immunocompromised. In general, the first group would avoid the use of live-virus vaccines, and in all cases, inflammatory bowel disease treatment would take precedence over vaccine risk. It is important to individualize vaccination schedules according to the type of patient, the treatment used and the disease pattern.In addition, patient with inflammatory bowel disease should be considered for the following vaccines: varicella vaccine, human papilloma virus, influenza, pneumococcal polysaccharide vaccine and hepatitis B vaccine.Entities:
Keywords: Crohn’s disease; Immunocompromised; Inflammatory bowel disease; Ulcerative colitis; Vaccines
Mesh:
Substances:
Year: 2013 PMID: 23538680 PMCID: PMC3602494 DOI: 10.3748/wjg.v19.i9.1354
Source DB: PubMed Journal: World J Gastroenterol ISSN: 1007-9327 Impact factor: 5.742